Ovarian suppression with leuprolide acetate: Comparison of luteal, follicular, and flare-up administration in controlled ovarian hyperstimulation for oocyte retrieval

[1]  K. P. Katayama,et al.  Short-term use of gonadotropin-releasing hormone agonist (Leuprolide) for in vitro fertilization , 1988, Journal of in Vitro Fertilization and Embryo Transfer.

[2]  Z. Rosenwaks,et al.  Short-term use of gonadotropin-releasing hormone agonist , 1988, Journal of In Vitro Fertilization and Embryo Transfer.

[3]  Z. Rosenwaks,et al.  Value of suppression with a gonadotropin‐releasing hormone agonist prior to gonadotropin stimulation for in vitro fertilization , 1989, Fertility and sterility.

[4]  Z. Rosenwaks,et al.  Follicle-stimulating hormone levels on cycle day 3 are predictive of in vitro fertilization outcome. , 1989, Fertility and sterility.

[5]  D. Meldrum,et al.  Routine pituitary suppression with leuprolide before ovarian stimulation for oocyte retrieval. , 1989, Fertility and sterility.

[6]  K. Thomas,et al.  Hormonal changes induced by short-term administration of gonadotropin-releasing hormone agonist during ovarian hyperstimulation for in vitro fertilization and their consequences for embryo development. , 1989, Fertility and sterility.

[7]  A. Golan,et al.  Results of in vitro fertilization and embryo transfer by combined long-acting gonadotropin-releasing hormone analog D-Trp-6-luteinizing hormone-releasing hormone and gonadotropins. , 1989, Fertility and sterility.

[8]  D. Meldrum,et al.  Timing of initiation and dose schedule of leuprolide influence the time course of ovarian suppression. , 1988, Fertility and sterility.

[9]  R. Frydman,et al.  Comparison between flare up and down regulation effects of luteinizing hormone-releasing hormone agonists in an in vitro fertilization program. , 1988, Fertility and sterility.

[10]  R. Marrs,et al.  An alternate approach to controlled ovarian hyperstimulation in "poor responders": pretreatment with a gonadotropin-releasing hormone analog. , 1988, Fertility and sterility.

[11]  D. de Ziegler,et al.  Suppression of the ovary using a gonadotropin releasing-hormone agonist prior to stimulation for oocyte retrieval. , 1987, Fertility and sterility.

[12]  D. de Ziegler,et al.  Evolution of a highly successful in vitro fertilization-embryo transfer program. , 1987, Fertility and sterility.

[13]  J. Yovich,et al.  Reduced in‐vitro fertilization of human oocytes from patients with raised basal luteinizing hormone levels during the follicular phase , 1985, British journal of obstetrics and gynaecology.

[14]  G. Braunstein,et al.  Stimulation of LH fragments with reduced bioactivity following GnRH agonist administration in women. , 1984, The Journal of clinical endocrinology and metabolism.